v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (4,334) $ (2,989)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 2,081 2,093
Amortization of loan costs 607 184
Loss (gain) on interest rate hedge 128 (55)
Loss on sale of real estate 0 42
Equity based payment 654 1,799
Impairment 0 157
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) (370) (654)
Changes in operating assets and liabilities    
Due to/from related parties 3 (12)
Accounts payable and accrued expenses (682) (973)
Other assets 355 (28)
Accounts receivable 28 (921)
Net cash (used in) operating activities (1,530) (1,357)
Cash flows from investing activities:    
Capital expenditures (189) (254)
Proceeds from Note Receivable 3,120 0
Payments on sale of investment in real estate 0 (155)
Net cash provided by (used in) investing activities 2,931 (409)
Cash flows from financing activities:    
Proceeds from Line of Credit 1,453 0
Payments on notes payable (675) (6,251)
Proceeds from notes payable 0 5,900
Distributions to non-controlling interest holders (47) (46)
Loan fees 0 (604)
Share repurchase plan (265) 0
Shares repurchased for vesting of employee awards (113) 0
Preferred redemption payments (1,149) 0
Preferred dividend payments (273) 0
Net cash (used in) financing activities (1,069) (1,001)
Net change in cash and cash equivalents and restricted cash 332 (2,767)
Cash and cash equivalents and restricted cash, beginning of period 15,819 16,711
Cash and cash equivalents and restricted cash, end of period 16,151 13,944
Reconciliation of Cash and Cash Equivalents and Restricted Cash:    
Cash and cash equivalents at beginning of period 10,655 11,134
Restricted cash at beginning of period 5,164 5,577
Cash and cash equivalents and restricted cash, beginning of period 15,819 16,711
Cash and cash equivalents at end of period 11,617 9,149
Restricted cash at end of period 4,534 4,795
Cash and cash equivalents and restricted cash, end of period 16,151 13,944
Supplemental disclosures of cash flow information:    
Interest Paid 2,847 2,331
Non-cash investing and financing activities:    
Distributions declared not yet paid 88 528
Requested preferred redemptions not yet paid 826
Accrued capital expenditures 210
Accrued preferred distributions paid in common stock 0 711
Right of use asset and lease liability 0 332
Note receivable related to disposition of property 0 3,120
Equity shares issued in exchange for accrued compensation $ 0 $ 1,201

Source

HTML PDF
ZIP